Volume 65, Issue 4, Pages (April 2004)

Slides:



Advertisements
Similar presentations
Volume 80, Issue 2, Pages (July 2011)
Advertisements

Volume 65, Issue 1, Pages (January 2004)
Volume 65, Issue 4, Pages (April 2004)
Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice  Meera R. Krishnan, Congmiao.
Volume 63, Issue 4, Pages (April 2003)
Volume 64, Issue 5, Pages (November 2003)
Volume 81, Issue 2, Pages (January 2012)
Volume 66, Issue 3, Pages (September 2004)
Volume 69, Issue 4, Pages (February 2006)
Volume 61, Issue 2, Pages (February 2002)
Human renal epithelial cells produce the long pentraxin PTX3
Volume 61, Issue 4, Pages (April 2002)
Volume 55, Issue 2, Pages (February 1999)
Volume 60, Issue 6, Pages (December 2001)
Volume 60, Issue 5, Pages (November 2001)
Volume 68, Issue 2, Pages (August 2005)
Volume 65, Issue 5, Pages (May 2004)
Volume 66, Issue 6, Pages (December 2004)
Volume 66, Issue 6, Pages (December 2004)
Volume 72, Issue 7, Pages (October 2007)
Volume 62, Issue 6, Pages (December 2002)
Volume 66, Issue 5, Pages (November 2004)
Volume 56, Issue 6, Pages (December 1999)
Volume 64, Issue 5, Pages (November 2003)
Volume 66, Issue 4, Pages (October 2004)
Volume 68, Issue 1, Pages (July 2005)
Volume 64, Issue 4, Pages (October 2003)
A new mouse model of immune-mediated podocyte injury
Volume 55, Issue 2, Pages (February 1999)
Nrf2-deficient female mice develop lupus-like autoimmune nephritis1
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Volume 63, Issue 4, Pages (April 2003)
Volume 58, Issue 1, Pages (July 2000)
Volume 86, Issue 4, Pages (October 2014)
Volume 66, Issue 3, Pages (September 2004)
Volume 86, Issue 5, Pages (November 2014)
Volume 70, Issue 2, Pages (July 2006)
Volume 65, Issue 1, Pages (January 2004)
Regulatory interactions of αβ and γλ T cells in glomerulonephritis
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Volume 65, Issue 5, Pages (May 2004)
The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H–deficient mice  Jessy J. Alexander, Lee Chaves, Anthony Chang,
Volume 71, Issue 7, Pages (April 2007)
(A, B) ... (A, B) The frequencies of Tregs from patients with SLE (n = 50) and healthy controls (n = 20) are shown. (C) Data plots show the correlation.
Volume 81, Issue 2, Pages (January 2012)
Hongli Lin, Xiangmei Chen, Jianzhong Wang, Zhiheng Yu 
Volume 66, Issue 4, Pages (October 2004)
Volume 57, Issue 1, Pages (January 2000)
Volume 60, Issue 6, Pages (December 2001)
Volume 64, Issue 3, Pages (September 2003)
Volume 79, Issue 2, Pages (January 2011)
Volume 67, Issue 3, Pages (March 2005)
Volume 61, Issue 6, Pages (June 2002)
Volume 69, Issue 11, Pages (June 2006)
A.K.I. Kuroki, Masayuki Iyoda, Takanori Shibata, Tetsuzo Sugisaki 
Volume 67, Issue 4, Pages (April 2005)
Volume 60, Issue 5, Pages (November 2001)
Volume 64, Issue 3, Pages (September 2003)
Volume 67, Issue 4, Pages (April 2005)
Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF- induced mesangial cell migration  Kim Hansen, Christine K. Abrass 
Volume 68, Issue 3, Pages (September 2005)
Volume 63, Issue 1, Pages (January 2003)
Volume 67, Issue 6, Pages (June 2005)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Cultured human glomerular mesangial cells express the C5a receptor
Volume 68, Issue 5, Pages (November 2005)
Volume 58, Issue 5, Pages (November 2000)
Volume 65, Issue 5, Pages (May 2004)
Volume 61, Issue 3, Pages (March 2002)
Volume 78, Issue 3, Pages (August 2010)
Presentation transcript:

Volume 65, Issue 4, Pages 1290-1300 (April 2004) Endothelial adhesion molecules in glomerular lesions: Association with their severity and diversity in lupus models  Kimihiko Nakatani, Hiroshi Fujii, Hitoshi Hasegawa, Miho Terada, Norimasa Arita, Mitsuko R. Ito, Masao Ono, Satoru Takahashi, Kan Saiga, Shuhei Yoshimoto, Masayuki Iwano, Hideo Shiiki, Yoshihiko Saito, Masato Nose  Kidney International  Volume 65, Issue 4, Pages 1290-1300 (April 2004) DOI: 10.1111/j.1523-1755.2004.00537.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Representative histopathology of glomerular lesions in MRL/lpr mice [periodic acid-Schiff (PAS)] (500×). (A) Grade 0, normal glomerular lesion. (B) Grade 1, characterized by widening mesangial stalk, with an increase in cells and mesangial matrices. (C) Grade 2, characterized by increases in mesangial cells and matrices and by the infiltration of polymorphonuclear leukocytes, lymphocytes, and monocytes, accompanied by segmental wire loop–like lesions. (D) Grade 3, characterized by sclerosing lesions in addition to the manifestations of grade 2. Kidney International 2004 65, 1290-1300DOI: (10.1111/j.1523-1755.2004.00537.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Reverse transcription-polymerase chain reaction (RT-PCR) analyses of E-selectin, P-selectin, and vascular cell adhesion molecule-1 (VCAM-1) in glomeruli of MRL/lpr mice. (A) Five micrograms of total RNA from glomeruli were subjected to RT-PCR with specific primer sets (see Table 1) for mouse E-selectin, P-selectin, VCAM-1, and hypoxanthine long line phosphoribosyltransferase (HPRT). M.W. indicates the DNA length markers. Ratios of the densities of each band of E-selectin (B), P-selectin (C), and VCAM-1 (D) to that of HPRT on the same gel. Columns represent the means ± SD of each value from different experiments. Grade 0, N = 7; grade 1, N = 7; grade 2, N = 7; and grade 3, N = 5. *P < 0.005; **P < 0.001. Kidney International 2004 65, 1290-1300DOI: (10.1111/j.1523-1755.2004.00537.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Representative histopathology of glomerular lesions in SCID mice [periodic acid-Schiff (PAS)] (500×). (A) Lesions induced by the 2B11.3 clone, characterized by extreme cell proliferation with an accumulation of macrophage-like and polymorhonuclear cells. (B) Lesions induced by the 7B6.8 clone, characterized by hyaline deposits along the capillary wall and partially hyaline thrombi in the capillary lumen. Immunofluorescence staining of the glomerular lesions with anti-E-selectin antibodies (C and D) and anti-P-selectin antibodies (E and F). (C and E) Lesions induced by the 2B11.3 clone. (D and F) Lesions induced by the 7B6.8 clone. Kidney International 2004 65, 1290-1300DOI: (10.1111/j.1523-1755.2004.00537.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Reverse transcription-polymerase chain reaction (RT-PCR) analyses of E-selectin, P-selectin, and vascular cell adhesion molecule-1 (VCAM-1) in glomeruli of SCID mice injected with IgG3 producing hybridomas. (A) Five micrograms of total RNA from glomeruli were subjected to RT-PCR with specific primer sets (see Table 1) for mouse E-selectin, P-selectin, VCAM-1, and hypoxanthine phosphoribosyltransferase (HPRT). M.W. indicates DNA length markers. Ratios of the densities of each band of E-selectin (B), P-selectin (C), and VCAM-1 (D) to that of HPRT on the same gel. Columns represent the means ± SD of each value from different experiments. 2B11.3, N = 10; 7B6.8, N = 8; and 1G3, N = 8. *P < 0.005; **P < 0.001. Kidney International 2004 65, 1290-1300DOI: (10.1111/j.1523-1755.2004.00537.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Western blot analysis (A) and enzyme-linked immunosorbent assay (ELISA) (B) of soluble E-selectin (sE-selectin) in the L cell culture supernatant and the sera of SCID mice injected with the L cells. (A) Lane 1, culture supernatant of the L cells transfected with the sE-selectin vector; lane 2, culture supernatant of the L cells transfected with the control vector; lanes 3 to 5, sera of the SCID mice 7, 14, and 40days after injection of L cells transfected with the sE-selectin vector, respectively; and lane 6; sera of the SCID mice 40days after injection of control L cells. (B) Serum levels of sE-selectin in SCID mice bearing the L cells transfected with the sE-selectin vector or the control vector. The former had significantly increased sE-selectin in the days after the injection. Kidney International 2004 65, 1290-1300DOI: (10.1111/j.1523-1755.2004.00537.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 6 Representative histopathology of glomerular lesions in SCID mice bearing the soluble E-selectin (sE-selectin)–producing L cells (A, C, E, and G) and control L cells (B, D, F, and H), 25days after the injection of the 2B11.3 clone. Periodic acid-Schiff (PAS) staining (100×) (A and B), 400× (C and D), immunofluoresent staining with anti-IgG3 (E and F), and anti-E-selectin (G and H). Kidney International 2004 65, 1290-1300DOI: (10.1111/j.1523-1755.2004.00537.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 7 Comparative studies of SCID mice bearing the soluble E-selectin (sE-selectin)–producing L cells or control L cells 25days after injection of the 2B11.3 clone. (A) Index of glomerular lesions. Mean index of the mice with sE-selectin was significantly lower than that of the control mice. (B) Serum IgG3 levels detected by SRID. There was no significant difference between the groups. Serum levels of blood urea nitrogen (BUN) (C) and albumin (D). Significant differences were observed between two groups in both experiments. SRID, single radial immunodiffusion. Kidney International 2004 65, 1290-1300DOI: (10.1111/j.1523-1755.2004.00537.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 8 Reverse transcription-polymerase chain reaction (RT-PCR) analyses of E-selectin, P-selectin, vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1) in glomeruli of SCID mice bearing the soluble E-selectin (sE-selectin)-producing L cells (▪) or control L cells (□) 25days after injection of the 2B11.3 clone. Columns represent the means ± SD of each value from different experiments (N = 4, each). *P < 0.05 (E-selectin, P = 0.01); (P-selectin, P = 0.006); (ICAM-1, P = 0.02); **P = 0.0001. Kidney International 2004 65, 1290-1300DOI: (10.1111/j.1523-1755.2004.00537.x) Copyright © 2004 International Society of Nephrology Terms and Conditions